Drug cost burden on the elderly: government, corporations helping out

Human IgG antibody profiles differentiate between symptomatic patients with and without colorectal cancer.

Gut·2009

The functional outcome and recovery of patients admitted to an intensive care unit following drug overdose: a follow-up study.

Anaesthesia and intensive care·2009

Traveller health: prevalence of diabetes, pre diabetes and the metabolic syndrome.

Irish medical journal·2009

The prevalence and distribution of Mycobacterium bovis infection in European badgers (Meles meles) as determined by enhanced post mortem examination and bacteriological culture.

Research in veterinary science·2009

Effects of estrogen therapy on age-related differences in gray matter concentration.

Climacteric : the journal of the International Menopause Society·2009

Neuroleptics in the treatment of aggressive challenging behaviour for people with intellectual disabilities: a randomised controlled trial (NACHBID).

Health technology assessment (Winchester, England)·2009

Dispensing errors and counseling in community practice.

American pharmacy·1995

The role of the pharmacist in improving asthma care. National Asthma Education and Prevention Program.

American pharmacy·1995

Attention-deficit hyperactivity disorder: the pharmacist's role.

American pharmacy·1995

Cardiovascular Effects of Chronic GIPR and GLP-1R Agonism in Lean and Diet-Induced Obese Mice: Sex Differences and Dose-Dependent Remodeling.

American journal of physiology. Heart and circulatory physiology·2026

Method Development for Simultaneous Quantification of Anti-diabetic Drugs in Combined Solid Dosage Form: A Focus on Sulfonylureas, Biguanides, and Thiazolidinediones.

Current drug research reviews·2026

Specialty-based variation in glucagon-like Peptide-1 receptor agonist prescribing practices for adolescent obesity in Saudi Arabia.

Obesity pillars·2026

[The effects of methylprednisolone pulse therapy on glucose metabolism parameters in children with autoimmune and autoinflammatory diseases].

Problemy endokrinologii·2026

[Expert consensus on initial combination lipid-lowering therapy in patients with type 2 diabetes mellitus and hypertension (2026)].

Zhonghua nei ke za zhi·2026

Postbiotic Metabolites: Therapeutic Potential, Industrial Applications, Market Dynamics, and Regulatory Frameworks.

Probiotics and antimicrobial proteins·2026

Related Experiment Videos

Drug cost burden on the elderly: government, corporations helping out

Related Concept Videos

Human IgG antibody profiles differentiate between symptomatic patients with and without colorectal cancer.

The functional outcome and recovery of patients admitted to an intensive care unit following drug overdose: a follow-up study.

Traveller health: prevalence of diabetes, pre diabetes and the metabolic syndrome.

The prevalence and distribution of Mycobacterium bovis infection in European badgers (Meles meles) as determined by enhanced post mortem examination and bacteriological culture.

Effects of estrogen therapy on age-related differences in gray matter concentration.

Neuroleptics in the treatment of aggressive challenging behaviour for people with intellectual disabilities: a randomised controlled trial (NACHBID).

Dispensing errors and counseling in community practice.

The role of the pharmacist in improving asthma care. National Asthma Education and Prevention Program.

Attention-deficit hyperactivity disorder: the pharmacist's role.

Cardiovascular Effects of Chronic GIPR and GLP-1R Agonism in Lean and Diet-Induced Obese Mice: Sex Differences and Dose-Dependent Remodeling.

Method Development for Simultaneous Quantification of Anti-diabetic Drugs in Combined Solid Dosage Form: A Focus on Sulfonylureas, Biguanides, and Thiazolidinediones.

Specialty-based variation in glucagon-like Peptide-1 receptor agonist prescribing practices for adolescent obesity in Saudi Arabia.

[The effects of methylprednisolone pulse therapy on glucose metabolism parameters in children with autoimmune and autoinflammatory diseases].

[Expert consensus on initial combination lipid-lowering therapy in patients with type 2 diabetes mellitus and hypertension (2026)].

Postbiotic Metabolites: Therapeutic Potential, Industrial Applications, Market Dynamics, and Regulatory Frameworks.

Related Experiment Videos

Drug cost burden on the elderly: government, corporations helping out

Related Concept Videos

Related Articles